Fate Therapeutics, Inc.
Total Awards:
2
Award Value:
$11,934,448
Institution type:
For profit
Short Name:
Fate Therapeutics
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Barbara Hickingbottom | A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus | $7,934,448 |
| Late Stage Preclinical Projects | Dr Bob Valamehr | IND enabling development of FT516: A Natural Killer Cell Immunotherapy for Cancer Derived from a Human Inducible Pluripotent Stem Cell | $4,000,000 |
| Total: $11,934,448.00 |